S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NASDAQ:PRE

Prenetics Global (PRE) Stock Price, News & Analysis

$3.57
+0.01 (+0.28%)
(As of 03/27/2024 ET)
Today's Range
$3.25
$3.78
50-Day Range
$3.56
$5.67
52-Week Range
$3.24
$16.50
Volume
121,010 shs
Average Volume
59,937 shs
Market Capitalization
$32.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$60.00

Prenetics Global MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,580.7% Upside
$60.00 Price Target
Short Interest
Healthy
0.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.43mentions of Prenetics Global in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.40) to ($0.40) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.44 out of 5 stars

Medical Sector

517th out of 939 stocks

Holding & Other Investment Offices Industry

6th out of 14 stocks

PRE stock logo

About Prenetics Global Stock (NASDAQ:PRE)

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

PRE Stock Price History

PRE Stock News Headlines

Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
Prenetics Global (PRE) Earnings Dates & Reports
PRENW Prenetics Global Limited WT EXP 051827
Prenetics Global Stock (NASDAQ:PRE) Insider Trades
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
Prenetics Global: Q3 Earnings Insights
Prenetics Announces Third Quarter 2023 Financial Results
Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?
Prenetics Global Ltd Class A PRE
Prenetics Global Limited Announces Reverse Stock Split
Prenetics Global Limited - Ordinary Shares - Class A
Prenetics Announces Second Quarter 2023 Financial Results
PRE - Prenetics Global Limited
Prenetics Global (NASDAQ: PRE)
See More Headlines
Receive PRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prenetics Global and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/15/2023
Today
3/27/2024
Next Earnings (Estimated)
4/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:PRE
Fax
N/A
Employees
400
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$60.00
High Stock Price Target
$60.00
Low Stock Price Target
$60.00
Potential Upside/Downside
+1,580.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-190,450,000.00
Pretax Margin
-29.55%

Debt

Sales & Book Value

Annual Sales
$275.76 million
Book Value
$26.27 per share

Miscellaneous

Free Float
N/A
Market Cap
$32.63 million
Optionable
Not Optionable
Beta
-0.08
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Sheng Wu Yeung (Age 45)
    Co-Founder & CEO
  • Dr. Chi Hung Tzang Ph.D. (Age 49)
    Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board
  • Mr. Hoi Chun Lo (Age 39)
    Chief Financial Officer
  • Dr. Yung Ho Wong DPHIL (Age 42)
    Chief Technology Officer
  • Ms. Yvonne L. Wong
    Chief Corporate Development Officer
  • Ms. Samantha Kwok
    Vice President People & Culture
  • Dr. Senthil Sundaram M.D. (Age 50)
    Chief Clinical Officer
  • Mr. Avrom Boris Lasarow (Age 47)
    Chief Executive Officer of EMEA
  • Dr. Shih-Chang Ong M.D. (Age 46)
    Chief Medical Officer & Member of Scientific Advisory Board
  • Mr. Joel Neoh
    Chief Consumer Officer & MD for CircleDNA

PRE Stock Analysis - Frequently Asked Questions

Should I buy or sell Prenetics Global stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Prenetics Global in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" PRE shares.
View PRE analyst ratings
or view top-rated stocks.

What is Prenetics Global's stock price target for 2024?

1 analysts have issued twelve-month price targets for Prenetics Global's shares. Their PRE share price targets range from $60.00 to $60.00. On average, they anticipate the company's stock price to reach $60.00 in the next year. This suggests a possible upside of 1,580.7% from the stock's current price.
View analysts price targets for PRE
or view top-rated stocks among Wall Street analysts.

How have PRE shares performed in 2024?

Prenetics Global's stock was trading at $5.91 at the start of the year. Since then, PRE shares have decreased by 39.6% and is now trading at $3.57.
View the best growth stocks for 2024 here
.

Are investors shorting Prenetics Global?

Prenetics Global saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 8,000 shares, a drop of 39.4% from the February 29th total of 13,200 shares. Based on an average trading volume of 56,300 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.1% of the shares of the stock are sold short.
View Prenetics Global's Short Interest
.

When is Prenetics Global's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 2nd 2024.
View our PRE earnings forecast
.

How were Prenetics Global's earnings last quarter?

Prenetics Global Limited (NASDAQ:PRE) posted its quarterly earnings data on Friday, September, 15th. The company reported ($0.75) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.15. The company earned $5.70 million during the quarter. Prenetics Global had a negative trailing twelve-month return on equity of 3.89% and a negative net margin of 55.31%.

When did Prenetics Global's stock split?

Prenetics Global shares reverse split before market open on Tuesday, November 14th 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Who are Prenetics Global's major shareholders?

Prenetics Global's stock is owned by many different retail and institutional investors. Top institutional shareholders include Prudential PLC (7.49%), Aspex Management HK Ltd (3.79%), Nomura Holdings Inc. (2.12%) and Nomura Holdings Inc. (2.12%).

How do I buy shares of Prenetics Global?

Shares of PRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PRE) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners